title: Reassessment of global benefit-risk assessment of antidepressants: venlafaxine XR and fluoxetine.
authors.forename: Roy N
authors.initials: RN
authors.lastname: Tamura
authors.forename: Yili
authors.initials: Y
authors.lastname: Lu
mesh_terms: D000928:Antidepressive Agents / Q000627:therapeutic use*; D003511:Cyclohexanols / Q000627:therapeutic use*; D003627:Data Interpretation, Statistical; D003866:Depressive Disorder / Q000188:drug therapy*; D005473:Fluoxetine / Q000627:therapeutic use*; D006801:Humans; D016032:Randomized Controlled Trials as Topic; D018570:Risk Assessment; D016896:Treatment Outcome; D000069470:Venlafaxine Hydrochloride
chemical_list: D000928:Antidepressive Agents; D003511:Cyclohexanols; D005473:Fluoxetine; D000069470:Venlafaxine Hydrochloride